Natural history of human aberrant crypt foci and correlation with risk factors for colorectal cancer.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Oncology Report

• Publication date

  2012-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/or.2012.1631PMID 22246586
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Stepwise relationship between components of metabolic syndrome and risk of colorectal adenoma in a Taiwanese population receiving screening colonoscopy.

  2011cited by this paper
• Investigation of the Prevalence and Number of Aberrant Crypt Foci Associated with Human Colorectal Neoplasm

  2011cited by this paper
• Metformin suppresses azoxymethane‐induced colorectal aberrant crypt foci by activating AMP‐activated protein kinase

  2010cited by this paper
• Metformin Suppresses Colorectal Aberrant Crypt Foci in a Short-term Clinical Trial

  2010cited by this paper
• Cancer Statistics, 2010

  2010cited by this paper
• Reliability and accuracy of the endoscopic appearance in the identification of aberrant crypt foci.

  2009cited by this paper
• Association of visceral fat accumulation and plasma adiponectin with rectal dysplastic aberrant crypt foci in a clinical population

  2009cited by this paper
• Aberrant crypt foci: are they intermediate endpoints of colon carcinogenesis in humans?

  2009cited by this paper
• The natural history of aberrant crypt foci.

  2008cited by this paper
• Aberrant Crypt Foci as Precursors of the Dysplasia-Carcinoma Sequence in Patients with Ulcerative Colitis

  2008cited by this paper
• Aberrant Crypt Focus Size Predicts Distal Polyp Histopathology

  2008cited by this paper
• Aberrant crypt foci: what we know and what we need to know.

  2007cited by this paper
• Epidemiology of colonic aberrant crypt foci: review and analysis of existing studies.

  2007cited by this paper
• Aberrant crypt foci in patients with a positive family history of sporadic colorectal cancer.

  2007cited by this paper
• Assessment of Rectal Aberrant Crypt Foci by Standard Chromoscopy and its Predictive Value for Colonic Advanced Neoplasms

  2006cited by this paper
• Rectal Aberrant Crypt Foci Identified Using High-Magnification-Chromoscopic Colonoscopy: Biomarkers for Flat and Depressed Neoplasia

  2005cited by this paper
• Risk Factors for Colorectal Cancer in Relation to Number and Size of Aberrant Crypt Foci in Humans

  2005cited by this paper
• Relationship of aging and tobacco use with the development of aberrant crypt foci in a predominantly African-American population.

  2005cited by this paper
• Epidemiology, treatment and chemoprevention in colorectal cancer.

  2003cited by this paper
• Colorectal carcinoma in black and white race

  2003cited by this paper
• Endoscopic identification and quantification of aberrant crypt foci in the human colon.

  2002cited by this paper
• Aberrant crypt foci of the colon as precursors of adenoma and cancer

  1998cited by this paper
• Detection of aberrant crypt foci by magnifying colonoscopy.

  1997cited by this paper

• Leukotriene Receptor Antagonist Therapy for the Chemoprevention of Human Rectal Aberrant Crypt Foci: Nonrandomized, Open-Label, Controlled Trial.

  2022cites this paper
• The efficacy of aspirin and metformin combination therapy in patients with rectal aberrant crypt foci: a double-blinded randomized controlled trial

  2020cites this paper
• The efficacy of a leukotriene receptor antagonist in the treatment of human rectal aberrant crypt foci: a nonrandomized, open-label, controlled trial

  2020cites this paper
• Associations of dietary fat with risk of early neoplasia in the proximal colon in a population-based case–control study

  2018cites this paper
• The distribution of human rectal aberrant crypt foci and criteria for defining the counting area.

  2017cites this paper
• Association between factors associated with colorectal cancer and rectal aberrant crypt foci in humans.

  2015cites this paper
• The Role, Significance and Applicability of Aberrant Crypt Foci in Clinical Practice

  2014cites this paper
• Relationship of human rectal aberrant crypt foci and formation of colorectal polyp: One-year following up after polypectomy.

  2012cites this paper
• Eicosapentaenoic acid (EPA) efficacy for colorectal aberrant crypt foci (ACF): a double-blind randomized controlled trial

  2012cites this paper